• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers

Cardio3 BioSciences publishes its first Letter to Shareholders

February 7, 2014 By Celyad

Mont-Saint-Guibert, Belgium, –Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces today the publication of its first Letter to Shareholders.

In this first issue, Cardio3 BioSciences takes stock of its activities in 2013 and early 2014 and looks in detail at cardiopoiesis, its proprietary cell programming platform. It also features an interview with Dr William Wijns, who looks at cell regeneration, and the similarities and differences between the Cardio3 BioSciences technology and the work of Professor Yamanaka, who won the Nobel Prize in Medicine in 2012.

Visit the Cardio3 BioSciences website at www.c3bs.com or follow this link http://www.c3bs.com/en/letter-shareholders-february-2014 to go straight to the Cardio3 BioSciences Letter to Shareholders.

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help improve it by collecting statistics on how visitors use our website. By clicking on "I accept", you allow us to place these analytics cookies. We also use cookies that are necessary for the good functioning of our website. You can find out more information about the cookies we use by visiting our Cookie Policy. I acceptI refuseCookie Policy